MY ACCOUNT | NEWSLETTER |

Pig vaccine market to exceed 7% growth


The global market for porcine vaccines is expected to grow by a CAGR of 7.01% across the forecast period of 2022 to 2026, according to market analysis company, Technavio. By the end of the period, the dollar value of growth is projected to reach $794.67 million. The market is forecast to grow 6.2% in 2022 in year over year growth. 

The degree of growth is projected based on the rise of porcine diseases worldwide and efforts to quell their spread. The array of vaccines available are useful in stemming the spread of diseases such as PRRS and porcine circovirus-associated disease (PCVAD). However, growth will be moderated by a lack of veterinarians skilled in treating porcine disease worldwide coupled with adequate facilities. 

Within the porcine vaccine market, the strongest growth by geography is expected to be the United States. The area is forecast to make up 42% of the global market’s value based on the increasing number of dollars being spent on animal healthcare.

When viewing the market by segment of vaccine type, the IV segment is expected to attain a major role in the forecast period. Such technique requires skill to inject intravenously or intramuscularly and not allow the therapy to remain in tissues at the injection site, which can lead to an illegal level of accumulation. 


Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Prevalence of feline leukemia virus infection and serum antibodies against feline immunodeficiency virus in unowned free-roaming cats

Like0
Dislike0

Additive manufacturing to veterinary practice: Recovery of bony defects after the osteosarcoma resection in canines

Like0
Dislike0

Antimicrobial drug use in poultry

Like0
Dislike0

New hope and compassionate care for animal patients in pain

Like0
Dislike0

Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top